Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections
causing pneumonia and bronchiolitis in infants. RSV also causes serious illness in elderly …

Development of an RSV vaccine for infants has been hindered by the lack of an ideal animal
model that exhibits disease, and the challenge of effectively immunizing very young infants …

Human respiratory syncytial virus (HRSV) is a major cause of upper and lower respiratory
tract illness in infants and young children worldwide. Despite its importance as a respiratory …

Despite its impact on global health, there is no vaccine available for the prevention of
respiratory syncytial virus (RSV) infection. Failure to develop a licensed vaccine is not due to …

Respiratory syncytial virus (RSV) is the leading cause of serious lower respiratory track
illness causing bronchiolitis and some mortality in infants and the elderly. Despite decades …

Respiratory syncytial virus (RSV) was first isolated from chimpanzees in 1955, and shortly
thereafter from young children, and recognized as an important cause of serious lower …

Respiratory syncytial virus (RSV) is a major cause of bronchiolitis and pneumonia in young
children and the elderly. Despite its clinical importance, there is no licensed vaccine …

RSV is a major cause of respiratory illness in infants under 2 years of age. Evidence is
accumulating that it is also underestimated as a cause of respiratory infection in adults, the …

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract viral disease
in infants and young children. Presently, there are no explicit recommendations for RSV …

Respiratory syncytial virus (RSV) is an important cause of respiratory disease causing high
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …